LAM Treatment Alliance
The LAM Treatment Alliance fosters and funds high-impact medical research. The organization's exclusive mission is to find a treatment for LAM (lymphangioleiomyomatosis) in the fastest time possible. Each year, this disease strikes thousands of women in the U.S. and many more worldwide. It usually affects women in their childbearing yeras. In 2005, founder Amy Farber was diagnosed with LAM. After researching the disease and learning that there was no treatment, Amy created the LAM Treatment Alliance to accelerate the pace of research. The Alliance works as a think-tank and funder exclusively focused on finding a treatment for LAM. The LAM Treatment Alliance funds targeted scientific research, hosts biannual and ad hoc problem-solving Summits with leading scientists from around the world, and convenes researchers through a monthly seminar series at Harvard Medical School.